The results of gene expression cluster analysis for all cyclin-dependent kinase inhibitors (CDKI) in SIX6-positive and -negative T-ALL cell lines indicated a general regulatory relationship between SIX6 and CDKI expression in T-ALL (Fig 6A). Here, SIX6 is linked to acute lymphoblastic leukemia.